Mar 16, 2021
Full article: https://www.ajronline.org/doi/abs/10.2214/AJR.20.25207
Shrav Sridhar MD, discusses a retrospective study in which target-specific prostate cancer detection rate in a cohort of patients who underwent in-bore MRI biopsy was compared to the rate in a cohort of patients who underwent ultrasound-MRI fusion-guided biopsy.